Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin for Hospitalized COVID-19 Patients
NCT04386447Phase 2Withdrawn
- Sponsor
- Azienda Ospedaliero-Universitaria di Parma
- Start
- Sep 2020
- Primary completion
- Oct 2020
- Countries
- 2
01
Overview
A Phase 2 trial of oxytocin in coronavirus disease 2019 (COVID-19), sponsored by Azienda Ospedaliero-Universitaria di Parma. Planned start Sep 2020; status: withdrawn.
02
Drugs
oxytocin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04386447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04386447.